The results demonstrated that quercetin reversed docetaxel resistance in prostate cancer via the mechanisms as follows (Figure 8): the activation of androgen receptor and PI3K/Akt pathway, the appearance of remarkable mesenchymal and stem-like cell phenotypes, and the P-gp expression. The gene discussed is AKT1; the disease is prostate carcinoma.